医学
肺癌
内科学
欧洲癌症与营养前瞻性调查
肿瘤科
生物标志物
人口
队列
癌胚抗原
癌症
前瞻性队列研究
队列研究
环境卫生
生物化学
化学
作者
Florence Guida,Nan Sun,Leonidas E. Bantis,David C. Muller,Li Peng,Ayumu Taguchi,Dilsher Dhillon,Deepali L. Kundnani,Nikul Patel,Qingxiang Yan,Graham Byrnes,Karel G.M. Moons,Anne Tjønneland,Salvatore Panico,Claudia Agnoli,Paolo Vineis,Domenico Palli,Bas Bueno‐de‐Mesquita,Petra H. Peeters,Antonio Agudo
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2018-07-12
卷期号:4 (10): e182078-e182078
被引量:165
标识
DOI:10.1001/jamaoncol.2018.2078
摘要
This study provided a proof of principle in showing that a panel of circulating protein biomarkers may improve lung cancer risk assessment and may be used to define eligibility for computed tomography screening.
科研通智能强力驱动
Strongly Powered by AbleSci AI